Aims: Despite increased recognition as a chronic disease, obesity remains greatly underdiagnosed and undertreated. We aimed to identify international perceptions, attitudes, behaviours and barriers to effective obesity care in people with obesity (PwO) and healthcare professionals (HCPs).
| INTRODUCTION
Obesity is a serious, chronic, relapsing disease with a high prevalence and a substantial unmet medical need. 1, 2 This complex disease is influenced by multiple factors including genetics, physiological factors, psychological issues and environmental variables, both physical and social, and it affects individuals of all ages and regions. [2] [3] [4] Obesity is associated with multiple complications and an increased risk of disability and mortality. [5] [6] [7] Individuals living with obesity experience stigma, discrimination and a negative impact on both mental and health-related quality of life. 4, 7, 8 Treatment guidelines for people with obesity (PwO) typically recommend lifestyle interventions with addition of pharmacotherapy if response to dietary, physical activity and behavioural changes alone is insufficient to reach or maintain the recommended goal of 5%-10% loss in body weight. [9] [10] [11] [12] [13] [14] [15] Bariatric surgery should be considered for severe cases (body mass index [BMI] ≥40 kg/m 2 or ≥35 kg/m 2 with obesity-related complications) and may be considered for PwO (BMI ≥30 kg/m 2 ) with poorly controlled type 2 diabetes. [9] [10] [11] [12] [13] [14] [15] Despite the availability of these guidelines, in practice, PwO experience variable care. [16] [17] [18] The Awareness, Care, and Treatment In Obesity maNagement (ACTION) survey study conducted in the USA identified low rates of obesity diagnosis and management. 19 In another survey of 1506 healthcare professionals (HCPs) in the USA, most (84%) demonstrated limited knowledge of obesity treatment guidelines. 20 An international study of 335 HCPs suggested a disconnect between HCPs' confidence in their ability to manage patients with excess weight and their effectiveness in achieving weight loss goals. 21 To improve the quality of, and access to, obesity care globally, a better understanding of the disease and the way those with obesity are currently, and should be, managed is required. The objective of the ACTION International Observation (ACTION-IO) study was to identify the perceptions, attitudes and behaviours of PwO and HCPs and to assess the potential barriers to effective obesity care on an international scale. Here we report the primary results from the ACTION-IO study which, to our knowledge, is the largest international survey of PwO and HCPs to date.
| METHODS

| Study design and participants
The ACTION-IO study was a cross-sectional, non-interventional, descriptive study that collected data via an online survey conducted by a third-party vendor (KJT Group, Honeoye Falls, New York), utilizing existing databases/panels in 11 countries across different world regions (Australia, Chile, Israel, Italy, Japan, Mexico, Saudi Arabia, South Korea, Spain, the UAE and the UK) between 4 June 2018 and 15 October 2018. It was intended to also include Brazil, but it was not possible to obtain local ethics committee approval within the required timelines. Eligible PwO were 18 years or older and were residents of a participating country, with a current BMI, based on self-reported height and weight, of at least 30 kg/m 2 or at least 25 kg/m 2 in Japan and South Korea, as per country-specific definitions of obesity. 22 PwO were excluded if they declined to provide information concerning income, with the exception of Mexico as required by the local ethics committee, or concerning race/ethnicity, in Australia and the UAE only, if they were pregnant, if they participated in intense fitness or body building programmes or if they had experienced significant, unintentional weight loss during the past 6 months. Eligible HCPs were medical practitioners in a participating country, who had been in practice for 2 years or more, with at least 70% of their time involved in direct patient care and who had seen 100 or more patients during the past month, at least ten of whom had a BMI of at least 30 kg/m 2 , or 25 kg/m 2 in Japan and South Korea. HCPs specializing in general, plastic or bariatric surgery were excluded.
All respondents provided electronic informed consent prior to initiation of the screening questions and survey. A local ethics committee/independent review board approved the questionnaires in Australia, Israel, Mexico, Saudi Arabia, South Korea, Spain, the UAE and the UK, where such approval was required. For Chile, Italy and Japan, ethical approval was determined to be non-essential for a study of this nature based on regulatory standards and precedent. The study complied with all laws and regulations regarding management of personal information as required by the participant's country of residence and the European General Data Protection Regulation. The study was conducted in accordance with the Guidelines for Good Pharmacoepidemiology Practices 23 and is registered with ClinicalTrials.gov, number NCT03584191.
| Survey development and pre-testing
Two questionnaires, one for PwO and one for HCPs (Appendix S1, pages 28-139), were developed by an international steering committee of obesity experts, representing primary care, medical specialities and psychology, from the participating countries, in addition to three medical doctors employed by the sponsor, Novo Nordisk. The questionnaires were based on those used in the ACTION US 19 and ACTION Canada studies, 24 with minor modification or removal of some original questions to reduce survey length, increase data quality and ensure that questions were relevant to the study objectives. KJT Group conducted 60-minute web-assisted pre-tests with four PwO and four HCPs in each country; participants took the survey online while speaking with a moderator by telephone, or in-person in Japan, Saudi Arabia, South Korea, and the UAE. This was to assess clarity, face validity and relevance of the questions. Surveys were designed to facilitate comparisons within and across respondent types.
| Procedures
KJT Group oversaw all aspects of data collection and reporting. Data were collected through an online survey programmed by KJT Group, using Decipher Survey Software (FocusVision Worldwide Inc., Stamford, Connecticut). To reduce PwO sampling bias and ensure that the group was largely representative of the general population, the outbound sample was sent according to pre-determined demographic targets based on gender, age, income, race/ethnicity, in select countries, and region. Targets were established based on data from the 2011
International Standard Classification of Education and the US Census
Bureau, International Data Base and other public data. Prior to participation, respondents were blinded to the specific study goals, being informed that the purpose was "to determine treatment experiences of patients with a specific condition". All individuals could access the first part of the survey, and an initial set of screening questions determined eligibility based on the demographic targets; subsequently, only respondents who had obesity, as determined from their self-reported height and weight, and who met the other eligibility requirements as detailed in the Study design and participants section, proceeded into the full survey. Demographic targets were monitored throughout data collection to ensure population representativeness.
Respondents were compensated for their time and were recruited, for the most part, via online panel companies to whom they had given permission to be contacted for research purposes (Appendix S1, page 2). Respondents were recruited through email where possible, with telephone and in-person recruitment also used for PwO in Saudi Korea and the UAE (Appendix S1, page 2). All respondents could suspend taking the survey at any time and for any reason at any part of the survey. Participants were allowed to complete the survey only once, as assessed by prior online consent and digital fingerprinting (Appendix S1, page 2). To avoid bias, questionnaire items were carefully phrased and presented in the same order for each respondent and items in a list were displayed alphabetically, categorically, chronologically or randomly, as relevant for each response set.
| Outcomes
Outcomes were measured by multiple item selection (weight loss motivators, effective weight loss methods, types of weight management goals, most helpful information for patients concerning weight loss, responsibility for improving health of PwO, most helpful support for weight loss and ways information concerning weight loss management is received), numeric response (proportion of PwO who made a serious weight loss effort), single item selection (response to weight loss discussions), end-anchored 5-point Likert agreement scales (attitudes toward obesity, attitudes toward prescription weight loss medication and surgery, weight loss barriers, obesity and weight management, and the degree to which healthcare and society are meeting the needs of PwO), fully anchored 5-point Likert scales (effectiveness of guidelines for treating obesity) and by ranking (top factors for improving weight loss outcomes). Some of these outcomes will be published separately.
| Analysis
The target sample size, based on 12 participating countries, was 
| RESULTS
A total of 14 502 PwO and 2785 HCPs completed the survey (Table 1 and Figure S1 ) as per the target sample size for 11 participating countries. The mean response rate was 20% for PwO and 17% for HCPs; the mean eligibility rate was 19% for PwO and 61% for HCPs; and the mean completion time was 28 minutes for PwO and 35 minutes for HCPs (Appendix S1, page 5).
A total of 68% of PwO and 88% of HCPs agreed with the statement that obesity is a chronic disease ( Figure S2A ). Most PwO (82%) and HCPs (76%) believed that obesity has a large impact on overall health ( Figure S2B ). In comparison, 75%-85% of PwOs and 82%-93%
of HCPs stated that diabetes, stroke, cancer or chronic obstructive pulmonary disease has a large impact on overall health. Despite recognizing obesity as a disease that impacts overall health, most PwO assumed full responsibility for weight loss (81%) and considered lifestyle a key factor in their struggle with obesity (63%) (Figure 1 ; see Figure S3 for complete data). Also, 30% of HCPs placed the responsi- Only approximately half of all PwO had discussed their weight with an HCP in the past 5 years ( Figure 3A ). It took a median of 3 years and a mean of 6 years between the reported time that PwO first began struggling with excess weight or obesity and when they first had a weight management conversation with an HCP ( Figure 3B ). Moreover, 46% of the PwO who discussed weight with an HCP initiated the conversation themselves ( Figure S7A ). In contrast, on average, HCPs reported discussing weight with 68% of their patients with obesity, with the patient initiating the conversation only one third of the time ( Figure S7B ). The main reason provided by HCPs for initiating a weight management conversation was obesity-related complications ( Figure S8 ). ( Figure S10A ). On average, HCPs scheduled follow-up appointments with 44% of their patients to discuss obesity; 55% of HCPs reported that patients kept these follow-up appointments always or most of the time ( Figure S10B ).
Among all PwO, 41% would set themselves an ambitious weight loss target of 11%-20% (overall mean 16%) ( Figure S11A ). PwO reported receiving similar recommended targets from HCPs (overall mean 17%) ( Figure S11B ). The weight management goals most frequently selected by PwO were to reduce the risks associated with excess weight and to prevent a health condition (46%) and to improve appearance (33%) ( Figure S12 ).
The most frequent methods for managing weight discussed between PwO and HCPs were general improvement in eating habits and general increase in physical activity level, whereas specific diet or exercise programmes, tracking, weight loss medications and bariatric surgery were less likely to have been discussed ( Figure S13A ). Referrals to specialists were recommended infrequently ( Figure S13A ).
General improvements in eating habits and physical activity were perceived to be highly effective by most PwO and HCPs; however, more PwO than HCPs perceived weight loss medications and bariatric surgery to be effective ( Figure S13B ).
A total of 35% of PwO found that conversations with an HCP concerning weight management were very or extremely helpful ( Figure S14 ); and 68% of PwO liked the fact that their HCP brought up the subject of weight, or would like them to do so ( Figure 3C ).
Conversations with HCPs concerning weight management can be quite motivating and positive for PwO, with 64% reporting positive feelings after such a conversation ( Figure 3D ). Negative feelings after a conversation concerning weight loss were reported by 44% of PwO.
However, only 3% of PwO reported feeling offended ( Figure 3D ). see Figure S15 for complete data). More than half of the HCPs surveyed indicated that the limited appointment time is also a factor in not discussing weight loss (Figure 4 ). Data concerning other outcomes are presented in Figures S16-S19. Obesity is recognized as a chronic disease by several national and international organizations including the World Obesity Federation, 1 the European Association for the Study of Obesity, 11 The Obesity Society, 25 the American Medical Association 26 and the UK Royal College of Physicians. 27 Obesity involves a genetic predisposition and specific pathophysiological alterations, and it is not simply the result of lifestyle. 3, 4 However, only 26% of PwO in this study believed that their HCP has a responsibility to actively contribute to their weight loss efforts. Other studies have previously highlighted a disconnection between perceptions and actions. In a study in Australia, 78% of PwO Compared with the US ACTION study, a smaller proportion of PwO in this international study had discussed their weight with an HCP in the past 5 years (US ACTION, 71%; ACTION-IO, 54%); but among those, a greater proportion had received a diagnosis of obesity (US ACTION, 55%; ACTION-IO, 67%). 19 A similar proportion of PwO in the USA and internationally thought weight loss was completely their responsibility (US ACTION, 82%; ACTION-IO, 81%), and this was the main reason that PwO did not initiate a weight management conversation with an HCP in both studies. 19 In the USA, HCPs cited lack of time as a main reason for not initiating weight loss conversations, 19 intervention or development of a management plan. 9, 15, 31 Our data suggest that PwO are motivated to engage in weight loss efforts and would like their HCPs to initiate a conversation about weight. This is consistent with a UK study showing that most patients found discussing their weight with an HCP appropriate and helpful. 32 As obesity is a chronic disease, there is also a need to improve referrals and follow-up appointments for management of obesity. Part of this effort calls for eradication of the prevalent stigmatizing attitudes that are highlighted in prior studies 33 Figure S15 for all reasons. HCPs = green; PwO = orange. Abbreviations: HCP, healthcare professional; PwO, people with obesity activity, as well as medical and surgical therapy, while emphasizing the value of a multidisciplinary approach; [9] [10] [11] [12] [13] [14] [15] and increasing the frequency of diagnosis, follow-up appointments and referrals for effective evidence-based treatment. Obesity is an adiposity-based chronic disease, the complexity of which cannot be reflected by BMI alone, 35 and this may contribute to the reluctance of HCPs to provide a diagnosis of obesity. However, as recommended by current clinical practice guidelines, BMI is used for the initial assessment and diagnosis of obesity, taking into account factors such as age, ethnicity and muscularity. [9] [10] [11] [12] [13] [14] [15] Limitations of this study include the cross-sectional and descriptive nature, reliance on self-reported height and weight, which could underestimate BMI, and the accuracy of respondent recall. The fairly low response rates are typical for survey-based research (Appendix S1, page 5). Low response rates can affect sample representativeness and are a known limitation of this type of study. Internet access could also have restricted participation in some countries. Strengths of the study include the large number of respondents, the international nature of the study and the scientific rigor with which the survey was designed and implemented, including stratified sampling to provide a cohort representative of the general population.
Percentage of respondents in
| DISCUSSION
Overall, our data suggest that PwO are motivated to lose weight and that there is an opportunity for HCPs to initiate earlier, effective weight loss conversations with minimal fear of offence. PwO may not recognize the need to reduce excess weight until it has an impact on their health, further supporting the requirement for HCPs to raise the topic of weight before such obesity-related complications occur. Our study also reveals a global need for improved education of both PwO and HCPs concerning the biological basis and clinical management of obesity, and for a more positive attitude on the part of HCPs towards initiating discussions with PwO concerning weight and weight management.
